https://www.selleckchem.com/pr....oducts/k-ras-g12c-in
Vancomycin is commonly used as a first line therapy for gram positive organisms such as methicillin resistant . Vancomycin-induced acute kidney injury (V-AKI) has been reported in up to 43% of patients, especially in those with higher targeted trough concentrations. The precise mechanism of injury in humans remains elusive, with recent evidence directed towards proximal tubule cell apoptosis. In this study, we investigated the protein contents of urinary exosomes in patients with V-AKI to further elucidate biomarkers of me